Design and synthesis of a highly immunogenic, discontinuous epitope of HIV-1 gp120 which binds to CD4+ve transfected cells

Molecular Immunology

Volumn 33, Issue 2, 1996, Pages 171-178

  Cotton, Graham J ^a,b   Howie, Sarah E M ^a   Heslop, Ian ^b   Ross, James A ^c   Harrison, David J ^a   Ramage, Robert ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

discontinuous epitope; gp120; synthetic peptide

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELL LINE; CIRCULAR DICHROISM; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029870362     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(95)00110-7     Document Type: Article

References (23)

1. Banda N. K., Bernier J., Kurahara D. K., Kurrle R., Haigwood N., Sekaly R. P. and Finkel T. H. (1992) Crosslinking CD4 by human immunodeficiency virus gp120 primes T-cells for activation induced apoptosis. J. Exp. Med. 176, 1099-1106.
2. Celada F., Cambiaggi C., Maccari J., Burastero S., Gregory T., Patzer E., Porter J., McDanal C. and Matthews T. (1990) Antibody raised against soluble CD4-gp120 complex recognises the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. J. Exp. Med. 172, 1143-1150.
3. Dalgleish A. G., Beverley P. C. L., Clapham P. R., Crawford D. H., Greaves M. H. and Weiss R. A. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
4. Dimarchi R., Brooke G., Gale C., Cracknell V., Doel T. and Mowat N. (1986) Protection of cattle against foot and mouth disease by a synthetic peptide. Science 232, 639-641.
5. Finkel T. H. and Banda N. K. (1994) Indirect mechanisms of HIV pathogenesis; how does it kill T cells. Curr. Opin. Immun. 6, 605-615.
6. Gougeon M.-L., Garcia S., Heeney J., Tschopp R., Lecoeur H., Guetard D., Rame V., Dauguet C. and Montagnier L. (1993) Programmed cell death in AIDS related HIV an SIV infections. AIDS Res. Hum. Retrovir. 9, 553-563.
7. Groux H., Monte D., Bourrez J. M., Capron A. and Ameisen J. C. (1992) Activation induced death by apoptosis in CD4+ T-cells from human immunodeficiency virus infected asymptomatic individuals. J. Exp. Med. 175, 331-340.
8. Hopp T. P. and Woods K. R. (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc. natn. Acad. Sci. USA 78, 3824-3828.
9. Klatzman D., Champagne E., Chameret S., Gruest J., Guetard D., Hercend T. and Gluckman J. C. (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
10. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T. and Capon D. J. (1987) Delineation of a region of the human immunodeficiency virus type 1 critical for interaction with the CD4 receptor. Cell 50, 975-985.
11. Leonard C. K., Spellman W. M., Riddle L., Harris R. J., Thomas N. J. and Gregory T. J. (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265, 10,373-10,382.
12. McDougal J. S., Kennedy M. S., Sligh J. M., Cort S. P., Mawle A. and Nicholson J. K. A. (1986) Binding of HTLV-III/LAV to T4+ T-cells by a complex of the 110K viral protein and the T4 molecule. Science 231, 382-385.
13. McKeating J. A., Moore J. P., Ferguson M., Marsden H. S., Graham S., Almond J. W., Evans D. J. and Weiss R. A. (1992) Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120. Use in topological analysis of a CD4 binding site. AIDS Res. Hum. Retrovir. 8, 451-459.
14. Modrow S., Hahn B. H., Shaw G. M., Gallo R. C., Wong-Staal F. and Wolf H. (1987) Computer assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61, 570-578.
15. Olshevsky U., Helseth E., Furman F., Haseltine W. and Sodroski J. (1990) Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64, 5701-5707.
16. Pollard S. R., Rosa M. D., Rosa J. J. and Wiley D. C. (1992) Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO J. 11, 585-591.
17. Popovic M., Gallo R. C. and Mann D. L. (1985) OKT-4 antigen bearing molecule is a receptor for the human retrovirus HTLV-III. Clin. Res. 33, 560.
18. Provencher S. W. and Glockner J. (1981) Estimation of globular protein secondary structure from circular dichroism. Biochemistry 20, 33-37.
19. Ramage R. and Stewart A. S. J. (1993) Peptide synthesis: synthesis of the cysteine-containing peptides of biological and pharmaceutical interest, α-h-ANF and h-big endothelin. J. Chem. Soc. Perk. Trans. I 17, 1947-1952.
20. Ramage R., Green J., Muir T. W., Ogunjobi O. M., Love S. and Shaw K. (1994) Synthetic, structural and biological studies of the ubiquitin system; the total chemical synthesis of ubiquitin. Biochem. J. 299, 151-158.
21. Reed J. and Kinzel V. (1993) Primary structural elements responsible for the conformational switch in the envelope glycoprotein gp120 from human immunodeficiency virus type 1: LPCR is a motif governing folding. Proc. natn. Acad. Sci. USA 90, 6761-6765.
22. Reed J. and Kinzel V. (1994) Inhibitors of the conformational switch involved in CD4 binding by the env glycoprotein gp120 from the human immunodeficiency virus type 1 (HIV1). Biochemistry 33, 10993-10998.
23. Sattentau Q. J. and Moore J. P. (1991) Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174, 407-415.